BiotechTube
Home/Arovella/Dr Michelle Ferguson
DM

Dr Michelle Ferguson

Senior Director Research & Development

Arovella

Therapeutic Areas

Oncology

Arovella Pipeline

DrugIndicationPhase
ALA-101CD19+ B‑cell lymphomas and leukaemiasPreclinical
ALA-105Claudin‑18.2+ gastric, gastro‑oesophageal junction, and pancreatic cancersPreclinical

Leadership Team at Arovella

DM
Dr Michael Baker
CEO & Managing Director
DN
Dr Nicole van der Weerden
Chief Operating Officer
LM
Lachie Mallia
Chief Financial Officer
DA
Dr Andrew Nash
Non‑Executive Director
DD
Dr Deborah Barton
Non‑Executive Director
DR
Dr Robson Dossa
Senior VP Manufacturing & Quality
JC
Jacqui Cumming
Senior Director Clinical Development
View full Arovella profile